GWM
LGND icon

GK Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

GK Wealth Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$122K Buy
+389
New +$115K 0.07% 262

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return

GK Wealth Management's LGND Position: Q3 2026 in Review

GK Wealth Management opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 389 shares worth $122K. The stake represents 0.07% of the portfolio and ranks #262 among its holdings.

14 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • GK Wealth Management held 389 shares of Ligand Pharmaceuticals worth $122K as of Q3 2026.
  • Ligand Pharmaceuticals was a new GK Wealth Management position in Q3 2026.
  • Ligand Pharmaceuticals made up 0.07% of GK Wealth Management's portfolio in Q3 2026, its #262 holding.
  • 14 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.